Eyre Pharmaceutical Private Limited
About Eyre Pharmaceutical Private Limited
Data last updated:
Eyre Pharmaceutical Private Limited is a private limited company based in Fekamari, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 August 2024.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U47720AS2024PTC026868.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Hasho Rani and Abdur Rezzak Sheikh.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fekamari, Assam.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.37 Lakh. For the same year it recorded a net loss of ₹16,080 (net margin -4.8%) and EBITDA of ₹19,720 (EBITDA margin 5.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Abdur Rezzak Sheikh, Fulerchar Mankachar, Fekamari, Assam, India – 783135
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Eyre Pharmaceutical Private Limited FY 2025 filings available
Eyre Pharmaceutical Private Limited reported revenue of ₹3.37 Lakh for FY 2025.
Financial Statement Summary of Eyre Pharmaceutical Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | ₹19,720 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | -₹16,080 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Eyre Pharmaceutical Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 5.9% |
| Net Profit Margin | -4.8% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eyre Pharmaceutical are in the company report.
Financial statements from FY 2025
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Eyre Pharmaceutical Private Limited
Eyre Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasho Rani | Director | 13 Aug 2024 | 2 Years 1 Months | Current |
| Abdur Rezzak Sheikh | Director | 13 Aug 2024 | 2 Years 1 Months | Current |
Charges & Borrowings of Eyre Pharmaceutical Private Limited
Eyre Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Eyre Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Eyre Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eyre Pharmaceutical Private Limited
Eyre Pharmaceutical Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Abdur Rezzak Sheikh was appointed as Director on 13 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Eyre Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eyre Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eyre Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eyre Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eyre Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eyre Pharmaceutical Private Limited
Eyre Pharmaceutical is an active private limited company based in Fekamari, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 August 2024 (2+ years old) and is registered under CIN U47720AS2024PTC026868.
Eyre Pharmaceutical reported revenue of ₹3.37 Lakh for FY 2025.
Eyre Pharmaceutical has 2 current directors:
- Hasho Rani - Director
- Abdur Rezzak Sheikh - Director
Eyre Pharmaceutical reported a net loss of ₹16,080 (net margin -4.8%) and EBITDA of ₹19,720 (EBITDA margin 5.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Eyre Pharmaceutical is U47720AS2024PTC026868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eyre Pharmaceutical was incorporated on 13 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Guwahati.
Abdur Rezzak Sheikh was appointed as Director on 13 Aug 2024. Hasho Rani was appointed as Director on 13 Aug 2024.
The registered office of Eyre Pharmaceutical is at CO Abdur Rezzak Sheikh, Fulerchar Mankachar, Fekamari, Assam, India – 783135.
Eyre Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000.
Eyre Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.